Comprehensive Toxicological Assessments for the National Toxicology Program
国家毒理学计划的综合毒理学评估
基本信息
- 批准号:8051077
- 负责人:
- 金额:$ 1376.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcrylamidesAddressAdverse effectsAgreementAloe vera plantAlternative MedicineAnestheticsBrainCaffeineCardiovascular DiseasesCell DeathChemicalsChildhoodChondroitinChronicCitrus aurantiumCommunitiesComplementary and alternative medicineCreamDataDevelopmentDiethylhexyl PhthalateDiseaseDrug KineticsEndocrineEnvironmental ExposureEvaluationExposure toFuransGABA AgonistsGenerationsGlucosamineGoalsHazard AssessmentHealthHumanImmune systemKetamineLamivudineLegalLichen - organismLightMalignant NeoplasmsMedicineMetabolismMusN-MethylaspartateNanotechnologyNational Institute of Environmental Health SciencesNational Toxicology ProgramNelfinavirNeurosecretory SystemsNevirapineOralOrangesPhototoxicityPhysiologicalPigmentsPoisonRattusResearchSafetyScienceServicesSimulateSkinSunlightTestingTherapeuticTopical applicationToxic effectToxicokineticsToxicologyUltraviolet RaysUnited States Food and Drug AdministrationUnited States National Institutes of HealthUsneaZidovudineZucker Ratsauthoritybasecarcinogenicitydevelopmental neurotoxicitydiabetic ratdietary supplementsdisorder preventionefavirenznanoscalenervous system disordernonylphenolphthalatesprogramsreproductiveretinyl palmitateusnic acid
项目摘要
The primary goal of this project is to provide support of National Toxicology Program (NTP) hazard assessment activities targeted toward the prevention of diseases or adverse effects caused by environmental exposure to chemical and physical agents.
This project specifically supports an interagency agreement between the National Institute of Environmental Health Sciences (NlEHS) of the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA)
The National Toxicology Program (NTP) is an interagency program headquarted at NIEHS and was established by the Secretary of Health and Human Services to provide information about potentially toxic chemicals to regulatory and research agencies and the public, coordinate toxicology research and testing activities and strengthen the science base in toxicology.
This lAG addresses a need by the FDA to obtain comprehensive toxicological data on chemical and physical agents regulated by the FDA for which questions about safety existed, but where the FDA either had no legal authority to require the regulated community to provide such data or there was no sponsor for the needed testing. Potential diseases of concern that may be induced by these agents include cancer, reproductive and developmental effects, cardiovascular disease, neurological disease and effects on the immune system.
Agents under evaluation using this IAG include endocrine active agents, AIDS therapeutics, dietary supplements, complementary and alternative medicines, anesthetics used in pediatric medicine, and agents that can be activated on co-exposure to UV light.
该项目的主要目标是为国家毒理学计划(NTP)的危害评估活动提供支持,这些活动旨在预防因环境暴露于化学和物理制剂而引起的疾病或不良影响。
该项目专门支持美国国立卫生研究院(NIH)的国家环境健康科学研究所(NlEHS)和美国食品药品监督管理局(FDA)之间的机构间协议
国家毒理学计划(NTP)是一个跨部门计划,总部设在NIEHS,由卫生和人类服务部部长建立,旨在向监管和研究机构以及公众提供有关潜在有毒化学品的信息,协调毒理学研究和测试活动,并加强毒理学的科学基础。
本LAG解决了FDA需要获得FDA监管的化学和物理制剂的全面毒理学数据的问题,这些制剂存在安全性问题,但FDA没有法律的权力要求监管机构提供此类数据,或者没有申办者进行所需的试验。这些物剂可能诱发的令人关切的潜在疾病包括癌症、生殖和发育影响、心血管疾病、神经系统疾病和对免疫系统的影响。
使用该IAG评估的药物包括内分泌活性药物、艾滋病治疗药物、膳食补充剂、补充和替代药物、儿科药物中使用的麻醉剂以及可在共同暴露于紫外线时活化的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
其他文献
2022 Academy Member Benefits Update
- DOI:
10.1016/j.jand.2023.02.007 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:
- 作者:
- 通讯作者:
Toward Social Hospital -snapshot of medical information technologies
走向社会医院——医疗信息技术快照
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
鈴木 真生; ;若尾 あすか;松村 耕平;野間 春生;Tomohiro Kuroda - 通讯作者:
Tomohiro Kuroda
Structure and Magnetic Property of Spinel Ferrite Nanosheets Synthesized by Hydrothermal Method
水热法合成尖晶石铁氧体纳米片的结构与磁性能
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Yuki Kamei ; Yuki Makinose ; Ken-ichi Katsumata ; ; NOBUHIRO MATSUSHITA - 通讯作者:
NOBUHIRO MATSUSHITA
健康維持のための行動変容を働きかけるソーシャルシステムの開発
开发鼓励行为改变以保持健康的社会系统
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
鈴木 真生; ;若尾 あすか;松村 耕平;野間 春生 - 通讯作者:
野間 春生
微細加工による医療・創薬のためのバイオデバイス開発
通过微加工开发用于医疗和药物发现的生物设备
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Yuki Kamei ; Yuki Makinose ; Ken-ichi Katsumata ; ; NOBUHIRO MATSUSHITA;H. Ago;一木隆範 - 通讯作者:
一木隆範
的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString(' ', 18)}}的其他基金
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
抗菌药物耐药性生物制药产品开发的临床前服务
- 批准号:
10934774 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
Preclinical Services for Biopharmaceutical Product Development
生物制药产品开发的临床前服务
- 批准号:
10934767 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
Pharmacology Consulting Services in relation to Pharmaceutical Development with Pain expertise. 09/12/2023 - 09/11/2024
与具有疼痛专业知识的药物开发相关的药理学咨询服务。
- 批准号:
10949065 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
FRAMINGHAM HEART STUDY - TASK AREA C - GENETIC RESULTS REPORTING
弗雷明汉心脏研究 - 任务领域 C - 基因结果报告
- 批准号:
10974185 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
Virtual Kick off Meeting with NCI for MAS Analysis Pool
与 NCI 举行 MAS 分析池虚拟启动会议
- 批准号:
10974493 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - UNIVERSITY OF MINNESOTA FIELD CENTER.
年轻人冠状动脉风险发展 (CARDIA) 研究 - 明尼苏达大学实地中心。
- 批准号:
10901060 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC)
年轻人冠状动脉风险发展 (CARDIA) 研究 - 协调中心 (CC)
- 批准号:
10901063 - 财政年份:2023
- 资助金额:
$ 1376.44万 - 项目类别:
相似海外基金
Novel Polymerization System of Acrylamides in the Presence of the Polymers having the Lower Critical Solution Temperature in Water
具有较低水中临界溶液温度的聚合物存在下的新型丙烯酰胺聚合体系
- 批准号:
14550841 - 财政年份:2002
- 资助金额:
$ 1376.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




